Macquarie Mid Cap Growth Fund Y
WMGYX
NASDAQ- -
USD
- -
- -
- -
- -
(- -)
Recent
price
- -
P/E
ratio
- -
div
yld
- -
ROIC.AI
Capital Structure
FRC
•
in mil. unless spec.Working Capital
FRC
•
in mil. unless spec.Growth Rates
FRC
•
in mil. unless spec.Quarterly Revenue
FRC
•
in mil. unless spec.Quarterly Earnings Per Share
FRC
•
in mil. unless spec.Quarterly Dividends Per Share
FRC
•
in mil. unless spec.- Similar Companies
- Business
- Macquarie Mid Cap Growth Fund Y (WMGYX) is a mutual fund managed by Macquarie Investment Management (MIM), a division of Macquarie Group Limited, that seeks long-term capital appreciation by investing primarily in common stocks of companies with medium market capitalizations demonstrating growth potential. The fund's portfolio includes equity securities of mid-cap U.S. companies across diverse sectors such as technology, healthcare, consumer discretionary, and industrials; it employs a growth-oriented investment strategy focusing on companies with above-average earnings growth, innovative business models, and strong competitive advantages. Shares of the fund are offered to institutional and retail investors through various share classes, including the Y class which features lower expense ratios and is targeted at investors with higher minimum investments. The fund operates within the U.S. equity mid-cap growth segment, targeting companies typically with market capitalizations between $2 billion and $10 billion at the time of purchase; its benchmark is the Russell Midcap Growth Index. Macquarie Investment Management, headquartered in Philadelphia, Pennsylvania, with global operations spanning North America, Europe, Asia-Pacific, and other regions, oversees the fund as part of its broader asset management platform serving institutional clients, financial advisors, and individual investors. Founded as part of Delaware Investments in 2007 and rebranded under Macquarie following the 2017 acquisition, the fund maintains a disciplined, research-driven approach with portfolio managers emphasizing bottom-up stock selection and risk management. Recent developments include portfolio manager transitions in 2023, with experienced growth equity professionals assuming lead roles to enhance the fund's focus on high-quality mid-cap growth names amid market volatility; additionally, the fund benefited from Macquarie Group's strategic expansion in U.S. asset management through organic growth and key hires in active equity strategies during 2024-2025. No major acquisitions, name changes, or structural reorganizations have been reported for the fund itself in the last two years, though Macquarie Group continued integrating sustainable investing considerations across its funds, including enhanced ESG analysis in mid-cap growth portfolios. The fund remains available through major brokerage platforms and financial intermediaries, with assets under management reflecting steady inflows driven by performance in technology and healthcare holdings.